COMPILATION OF PHARMACOKINETIC PARAMETERS OF BETA-ADRENERGIC BLOCKING-AGENTS

被引：0
作者：
RITSCHEL, WA [1 ]
机构：
[1] UNIV CINCINNATI,MED CTR,COLL MED,CINCINNATI,OH 45267
来源：
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1980年 / 14卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：746 / 756
页数：11
相关论文
共 86 条
[1]   PHARMACOLOGICAL EFFECTS AND SERUM LEVELS OF ORALLY ADMINISTERED ALPRENOLOL IN MAN [J].
ABLAD, B ;
HALLGREN, J ;
SOLVELL, L ;
JOHNSSON, G ;
ERVIK, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 5 (01) :44-&
[2]   COMBINED PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES ON ALPRENOLOL AND 4-HYDROXY-ALPRENOLOL IN MAN [J].
ABLAD, B ;
BORG, KO ;
JOHNSSON, G ;
REGARDH, CG ;
SOLVELL, L .
LIFE SCIENCES, 1974, 14 (04) :693-704
[3]  
ALDERMAN EL, 1973, CLIN PHARMACOL THER, V14, P175
[4]   IMPORTANCE OF 1ST-PASS ELIMINATION FOR INTERINDIVIDUAL DIFFERENCES IN STEADY-STATE CONCENTRATIONS OF ADRENERGIC BETA-RECEPTOR ANTAGONIST ALPRENOLOL [J].
ALVAN, G ;
LIND, M ;
MELLSTROM, B ;
VONBAHR, C .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (03) :193-205
[5]  
ALVAN G, 1977, CLIN PHARMACOL THER, V22, P316
[6]   ANTIARRHYTHMIC DRUGS - CLINICAL PHARMACOLOGY AND THERAPEUTIC USES [J].
ANDERSON, JL ;
HARRISON, DC ;
MEFFIN, PJ ;
WINKLE, RA .
DRUGS, 1978, 15 (04) :271-309
[7]  
ANTTILA M, 1976, ACTA PHARMACOL TOX, V39, P118
[8]  
AVERY GS, DRUG TREATMENT, P654
[9]  
AVERY GS, DRUG TREATMENT, P890
[10]  
AVERY GS, DRUG TREATMENT, P1212
123456789